Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Merck
Daiichi Sankyo
AstraZeneca
Johnson and Johnson
Medtronic
Moodys
Covington
Express Scripts

Generated: July 19, 2018

DrugPatentWatch Database Preview

Pentostatin - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for pentostatin and what is the scope of pentostatin patent protection?

Pentostatin
is the generic ingredient in two branded drugs marketed by Hospira Inc, Mylan Institutional, and West-ward Pharms Int, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for pentostatin. One supplier is listed for this compound.
Pharmacology for pentostatin
Medical Subject Heading (MeSH) Categories for pentostatin
Synonyms for pentostatin
(8R)-3-(2-Deoxy-?-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
(8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
(8R)-3-(4-HYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-3,4,7,8-TETRAHYDROIMIDAZO[4,5-D][1,3]DIAZEPIN-8-OL
(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol
(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol
(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol
(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol
(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-8-ol
(8R)-3,4,7,8-TETRAHYDRO-3-(2-DEOXY-BETA-D-ERYTHRO-PENTOFURANOSYL)-IMIDAZO[4,5-D][1,3]DIAZEPIN-8-OL
(R)-2'-Deoxycoformycin
(R)-3-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol
(R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol
(R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
(R)-Deoxycoformycin
2'-DCF
2'-Deoxycoformycin
2'-Dexoycoformycin
395575MZO7
53910-25-1
59979-24-7
63677-95-2
69196-00-5
70865-77-9
8R-2'-Deoxycoformycin
910P251
A3708
AB0010579
AC1L97UQ
AKOS024456918
AKOS032949742
API0005275
BDBM223291
BDBM22925
BIDD:GT0136
BRN 1223097
C02267
CAS-53910-25-1
CHEMBL1580
CI-825
CL 67310465
CL-67310465
Co-V
CO-Vidarabine
Coforin
Covidarabine
CS-0374
D00155
D0T3AD
DB00552
dCF
Deaminase inhibitor (PD)
Deaminase, inhibitor for adenosine arabinoside
Deoxycoformycin
DSSTox_CID_3436
DSSTox_GSID_23436
DSSTox_RID_77027
DTXSID2023436
EN300-222177
FPVKHBSQESCIEP-JQCXWYLXSA-N
GTPL4805
HE004037
HSDB 6547
HY-A0006
Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)-
Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-
IMIDAZO[4,5-D][1,3]DIAZEPIN-8-OL, 3-(2-DEOXY-B-D-ERYTHRO-PENTOFURANOSYL)-3,6,7,8-TETRAHYDRO-, (8R)-
IMIDAZO[4,5-D][1,3]DIAZEPIN-8-OL, 3-(2-DEOXY-BETA-D-ERYTHRO-PENTOFURANOSYL)-3,4,7,8-TETRAHYDRO-, (8R)-
J-523899
MFCD00078802
MolPort-020-006-031
MolPort-035-776-026
NCGC00182045-01
Nipent
Nipent (TN)
NSC 218321
NSC-218321
NSC218321
NU008238
Oncopent
PB12063
PD 81565
PD-81565
PD-ADI
Pentostatin (JAN/USAN/INN)
Pentostatin (PTN)
Pentostatin [USAN:INN:BAN:JAN]
Pentostatin, >=95% (HPLC)
Pentostatin(Deoxycoformycin)
Pentostatina
Pentostatina [INN-Spanish]
Pentostatine
Pentostatine [INN-French]
Pentostatinum
Pentostatinum [INN-Latin]
Pentostatn
Q-4464
RL03997
SCHEMBL2817
SR-01000883935
SR-01000883935-1
Tox21_113417
UNII-395575MZO7
Vidarbine
Vira A deaminase inhibitor
YK-176
Z2216208604
ZINC3806262

US Patents and Regulatory Information for pentostatin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional PENTOSTATIN pentostatin INJECTABLE;INJECTION 203554-001 Sep 19, 2014 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int PENTOSTATIN pentostatin INJECTABLE;INJECTION 077841-001 Aug 7, 2007 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc NIPENT pentostatin INJECTABLE;INJECTION 020122-001 Oct 11, 1991 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for pentostatin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hospira Inc NIPENT pentostatin INJECTABLE;INJECTION 020122-001 Oct 11, 1991 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Deloitte
QuintilesIMS
Merck
Daiichi Sankyo
Medtronic
Farmers Insurance
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.